Assessment of the protective effect of pneumococcal vaccination in preventing meningitis after cochlear implantation.

OBJECTIVES To examine if a 23-valent pneumococcal capsular polysaccharide vaccine (PPV23) reduces the risk of meningitis in healthy rats after cochlear implantation. DESIGN Interventional animal study. INTERVENTIONS Thirty-six rats (18 immunized and 18 unimmunized) received cochlear implantations and were then infected with Streptococcus pneumoniae via 3 different routes (hematogenous, middle ear, and inner ear) in numbers sufficient to induce meningitis. RESULTS The rats with implants that received PPV23 were protected from meningitis when the bacteria were delivered via the hematogenous and middle-ear routes (Fisher exact test P<.05). However, the protective effect of the vaccine in the rats with implants was only moderate when the bacteria were inoculated directly into the inner ear. CONCLUSIONS Our animal model clearly demonstrates that immunization can protect healthy rats with a cochlear implant from meningitis caused by a vaccine-covered serotype. This finding supports the notion that all current and future implant recipients should be vaccinated against S pneumoniae.

[1]  R. Shepherd,et al.  Threshold shift: Effects of cochlear implantation on the risk of pneumococcal meningitis , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[2]  R. Shepherd,et al.  Pneumococcal Meningitis Threshold Model: A Potential Tool to Assess Infectious Risk of New or Existing Inner Ear Surgical Interventions , 2006, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[3]  R. Shepherd,et al.  Pneumococcal Meningitis: Development of a New Animal Model , 2006, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[4]  W. Gstoettner,et al.  Does the 23‐Valent Pneumococcal Vaccine Protect Cochlear Implant Recipients? , 2005, The Laryngoscope.

[5]  E. Wald,et al.  Pneumococcal vaccines: do they prevent infection and how? , 2004, Current opinion in infectious diseases.

[6]  Owen Devine,et al.  Risk of bacterial meningitis in children with cochlear implants. , 2003, The New England journal of medicine.

[7]  R. Dagan,et al.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. , 2002, The Journal of infectious diseases.

[8]  A. Pusateri,et al.  Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats. , 1998, The Journal of trauma.

[9]  A. Ryan,et al.  Lymphocyte Trafficking to the Inner Ear a , 1997, Annals of the New York Academy of Sciences.

[10]  V. Paleri.  Inner Ear Immunology and Allergy: An Overview of Current Day Concepts , 1997, Ear, nose, & throat journal.

[11]  E. Hansen,et al.  Pathophysiology of blood-brain barrier alterations during experimental Haemophilus influenzae meningitis. , 1992, The Journal of infectious diseases.

[12]  G. Bruyn,et al.  Pneumococcal polysaccharide vaccines: Indications, efficacy and recommendations , 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[13]  E. Hansen,et al.  Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. , 1988, The Journal of clinical investigation.

[14]  W. Scheld,et al.  Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. , 1986, The Journal of clinical investigation.

[15]  G. Giebink,et al.  The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis. , 1981, Reviews of infectious diseases.

[16]  M. Hilleman,et al.  Protective efficacy of pneumococcal polysaccharide vaccines. , 1977, JAMA.

[17]  R. Austrian.  Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. , 1977, The Journal of infectious diseases.

[18]  J. Gerberding,et al.  Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. , 2005, MMWR. Morbidity and mortality weekly report.

[19]  M. Frosch,et al.  Infant Rat Model of Acute Meningitis , 1999 .

[20]  W. Scheld,et al.  Adult Rat Model of Meningitis , 1999 .